Pilot study (Phase II) of Pomalidomide, oral Desamethasone and very low-dose Cyclophosphamide in patients with refractory Multiple Myeloma who have received Lenalidomide and Bortezomib.
Phase of Trial: Phase II
Latest Information Update: 09 Nov 2016
At a glance
- Drugs Cyclophosphamide (Primary) ; Dexamethasone (Primary) ; Pomalidomide (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- 09 Nov 2016 New trial record